Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hartman

Showing results (341-350 of 459) with videos related to

Pageof 46
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 10, 2010
Tricyclic imidazole antagonists of the Neuropeptide S ReceptorB Wesley Trotter, Kausik K Nanda, Peter J Manley, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backboneDavid B Whitman, Ben C Askew, Le T Duong, et al.
Global Change Biology|June 1, 2019
Fixing a snag in carbon emissions estimates from wildfiresJeffrey E Stenzel, Kristina J Bartowitz, Melannie D Hartman, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
Development of pyridopyrimidines as potent Akt1/2 inhibitorsZhicai Wu, John C Hartnett, Lou Anne Neilson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 4, 2025
Ref-1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF-1αGabriella D Hartman, Anbukkarasi Muniyandi, Kamakshi Sishtla, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonistsPaul J Coleman, John D Schreier, Georgia B McGaughey, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Non-peptide alpha(v)beta(3) antagonists: identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraintJames J Perkins, L T Duong, Carmen Fernandez-Metzler, et al.
Journal of Medicinal Chemistry|November 8, 1996
Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugsJ H Hutchinson, J J Cook, K M Brashear, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDRZhicai Wu, Mark E Fraley, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
N-heterocyclic derived M1 positive allosteric modulatorsScott D Kuduk, Christina N Di Marco, Victoria Cofre, et al.
Pageof 46

Showing results (341-350 of 459) with videos related to

Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|July 10, 2010
Tricyclic imidazole antagonists of the Neuropeptide S ReceptorB Wesley Trotter, Kausik K Nanda, Peter J Manley, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backboneDavid B Whitman, Ben C Askew, Le T Duong, et al.
Global Change Biology|June 1, 2019
Fixing a snag in carbon emissions estimates from wildfiresJeffrey E Stenzel, Kristina J Bartowitz, Melannie D Hartman, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
Development of pyridopyrimidines as potent Akt1/2 inhibitorsZhicai Wu, John C Hartnett, Lou Anne Neilson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 4, 2025
Ref-1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF-1αGabriella D Hartman, Anbukkarasi Muniyandi, Kamakshi Sishtla, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonistsPaul J Coleman, John D Schreier, Georgia B McGaughey, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Non-peptide alpha(v)beta(3) antagonists: identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraintJames J Perkins, L T Duong, Carmen Fernandez-Metzler, et al.
Journal of Medicinal Chemistry|November 8, 1996
Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugsJ H Hutchinson, J J Cook, K M Brashear, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDRZhicai Wu, Mark E Fraley, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
N-heterocyclic derived M1 positive allosteric modulatorsScott D Kuduk, Christina N Di Marco, Victoria Cofre, et al.
Pageof 46